share_log

Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Officer Turitz Andrew

Teladoc Health | 4: Statement of changes in beneficial ownership of securities

Teladoc Health | 4:持股变动声明
美股sec公告 ·  03/20 16:14
Moomoo AI 已提取核心信息
Andrew Turitz, EVP of Corporate Development at Teladoc Health, Inc. (TDOC), was involved in a transaction on 03/19/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Turitz after the action.
Andrew Turitz, EVP of Corporate Development at Teladoc Health, Inc. (TDOC), was involved in a transaction on 03/19/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Turitz after the action.
Teladoc Health, Inc.(TDOC)企业发展执行副总裁安德鲁·图里兹于2024年3月19日参与了一项交易。公告中未披露该交易的具体细节,包括行动类型、状态、所涉股票数量、股票性质、交易价格和股票总价值。该报告也没有提供有关Turitz在行动后持有的股票数量的信息。
Teladoc Health, Inc.(TDOC)企业发展执行副总裁安德鲁·图里兹于2024年3月19日参与了一项交易。公告中未披露该交易的具体细节,包括行动类型、状态、所涉股票数量、股票性质、交易价格和股票总价值。该报告也没有提供有关Turitz在行动后持有的股票数量的信息。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息